RDHL - Redhill Biopharma Ltd

https://www.redhillbio.com

Momentum: Bearish

Recent News

Supreme Court Of New York Awards RedHill Biopharma Approx. $8 Million Plus Costs In Breach Of Contract Lawsuit - Redhill Biopharma ( NASDAQ:RDHL )

Benzinga • 9 months, 1 week ago • score: 0.35

RedHill Biopharma Ltd. RDHL, a specialty biopharmaceutical company, won a significant legal and financial victory, announcing a summary judgment in its favor and an award of about $8 million plus costs in its New York Supreme Court case against Kukbo Co. Ltd. of South Korea.

Bullish

RedHill Biopharma ( NASDAQ:RDHL ) Coverage Initiated by Analysts at StockNews.com

Stocknews.com • 1 year, 2 months ago • score: 0.27

Equities researchers at StockNews.com assumed coverage on shares of RedHill Biopharma ( NASDAQ:RDHL - Get Free Report ) in a research report issued to clients and investors on Monday. The firm set a "hold" rating on the biotechnology company's stock. Shares of NASDAQ RDHL opened at $0.39 on ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company is headquartered in Tel Aviv, Israel.

52W High

$12.50

52W Low

$1.06

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

4.24

Valuation

Rich

As of 2025-03-31 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

1428.57

EV/EBITDA (<8 favorable)

0.30

EV/Revenue (<3 favorable)

1.53

P/S (TTM) (<3 favorable)

0.41

P/B (<3 favorable)

203.21

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

0.00%

Institutions (25–75% balanced)

3.90%

Shares Outstanding

2,295,300

Float

11,472,206,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-03-31 (Overview)

Revenue (TTM)

8,043,000

Gross Profit (TTM)

4,851,000

EPS (TTM)

0.00

Profit Margin (>10% good)

-1.03%

Operating Margin (TTM) (higher better)

-0.70%

ROE (TTM) (>15% strong)

-17.09%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

3.82

Momentum

Bearish momentum

Value

0.0089

0.0001

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025